TARGETRIN THERAPEUTICS
Targetrin will develop novel drug candidates through the unique combination of industry leading novel cyclodextrin R&D and cGMP manufacturing capabilities of Cyclolab and EpiPharma’s proteomimetic peptide chemistry platform.
TARGETRIN THERAPEUTICS
Industry:
Biopharma Biotechnology Pharmaceutical
Address:
Budapest, Budapest, Hungary
Country:
Hungary
Status:
Active
Similar Organizations
NephroDI Therapeutics
NephroDI Therapeutics is a biopharmaceutical company that focuses on the concentration disorders of the kidney.
Phenex Pharmaceuticals
Phenex Pharmaceuticals is a drug discovery and development company focused on developing novel pharmaceuticals.
More informations about "Targetrin Therapeutics"
Targetrin Therapeutics Company Profile 2024: Valuation, Funding ...
Information on valuation, funding, acquisitions, investors, and executives for Targetrin Therapeutics. Use the PitchBook Platform to explore the full profile.See details»
Cyclolab and EpiPharma Form Joint Venture company …
Jan 11, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics LLC (Targetrin). Both founding companies will own 50 percent interest in the joint venture. Targetrin will develop novel drug …See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin ...
Jan 11, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics LLC (Targetrin). Both founding companies will own 50 percent interest in the joint …See details»
Targetrin Therapeutics - Crunchbase
Targetrin Therapeutics, Phenex Pharmaceuticals, and NephroDI Therapeutics operate in the pharmaceutical and drug development sector. Targetrin Therapeutics focuses on novel drug …See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin
Jan 11, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics LLC (Targetrin). Both founding companies will own 50 percent interest in the joint …See details»
EpiPharma, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
Explore EpiPharma, Inc. with its drug pipeline, therapeutic area, technology platform, 1 news.See details»
Cyclolab, EpiPharma form Joint Venture Company Targetrin …
Jan 14, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics. Both founding companies will own 50 percent interest in the joint venture. …See details»
Targetrin Therapeutics:Company Profile & Technical …
Targetrin Therapeutics is a company that provides Cyclodextrin, Drug candidate and more. Targetrin Therapeutics is headquartered in Hungary Budapest. Related Topics. Cyclodextrin …See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin
Jan 11, 2021 Cyclolab and EpiPharma announced that the companies have signed an agreement to form a joint venture specialty pharmaceutical company to develop and …See details»
Research programme: conjugated cyclodextrin-peptide …
Conjugated cyclodextrin-peptide therapeutics are being developed by Targetrin (JV of Cyclolab and EpiPharma) for the treatment of CNS and pulmonary diseases. Research programme: …See details»
Funding for Sinai Health Netherton Syndrome project from ... - TIAP
TIAP’s active portfolio consists of both early-stage assets and more than 60 companies in sectors such as therapeutics, medical devices and digital health/AI. The companies have raised in …See details»
Targetrin Therapeutics LLC: Drug pipelines, Patents, Clinical trials ...
Jun 17, 2023 0 Patents (Medical) associated with Targetrin Therapeutics LLC. Login to view more data. Pipeline. Pipeline Snapshot as of 17 Jun 2023. No pipeline posted. Login to keep …See details»
Target Therapeutics, Inc. Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Target Therapeutics, Inc. of Marlborough, MA. Get the latest business insights from Dun & Bradstreet.See details»
Gilead and Terray Therapeutics Announce Multi-Target Research ...
5 days ago About Terray Therapeutics Terray is an AI-powered biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small …See details»
Target Therapeutics - Crunchbase Company Profile & Funding
Target Therapeutics develops and markets disposable medical devices that are used in minimally-invasive procedures for the treatment of vascular diseases. ... 1,118 Number of Organizations …See details»
Gilead and Terray Therapeutics Announce Multi-Target Research ...
5 days ago About Terray Therapeutics Terray is an AI-powered biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small …See details»
Gilead and Terray Therapeutics Announce Multi Target Research ...
5 days ago About Terray Therapeutics Terray is an AI-powered biotechnology company with the technology, data, and mindset to radically change the way we discover and develop small …See details»
Cyclolab and EpiPharma Form Joint Venture company Targetrin ...
Jan 11, 2021 According to the agreement, the new joint venture will be named Targetrin Therapeutics LLC (Targetrin). Both founding companies will own 50 percent interest in the joint …See details»
Harnessing the biology of regulatory T cells to treat disease
6 days ago Regulatory T cells keep the immune system in check to maintain homeostasis and restrain inflammation. This Review discusses strategies to harness these cells therapeutically …See details»
Crowdsourced identification of multi-target kinase inhibitors for …
While some strive to develop ‘cleaner’ therapeutics that eliminate secondary targets, recent work has shown that multi-targeting therapeutics have key advantages for a variety of diseases. …See details»